Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01972308 · ClinicalTrials.gov registry record · NA

A Patient Advocate to Improve Real-world Asthma Management for Inner City Adults

A NA study of Asthma and Communication, sponsored by University of Pennsylvania.

Completed
Registry status
NA
Development phase
312
Enrollment target
1
Study location

NCT01972308: Completed NA study of Asthma and Communication, sponsored by University of Pennsylvania.

NCT01972308 is a NA study of Asthma and Communication that has completed, run by University of Pennsylvania. The registered enrollment target is 312 participants, below the 1,563-participant average among 374 other Asthma trials with a reported enrollment target (80% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01972308, a NA study of Asthma and Communication, has completed, sponsored by University of Pennsylvania.

COMPLETED
Registry status
NA
Development phase
312 participants
Enrollment target
1
Study location

Study Summary

Few interventions to improve asthma management have targeted low-income minority asthmatic adults and even fewer have focused on the real-world practice where care is provided for these patients. This project tests the effectiveness of a Patient Advocate as a practical and sustainable method of facilitating and maintaining communication between patient and provider and access to chronic care for adults with moderate or severe asthma recruited from clinics serving low-income urban neighborhoods. We compare the use of a Patient Advocate to current asthma care and test the Patient Advocate's cost-effectiveness.

Primary Outcome

Asthma Control Questionnaire: In a randomized controlled trial we will assess whether 6 months of the Patient Advocate Intervention improves asthma control relative to baseline compared with usual care (UC) and whether such a difference is sustained in the 6 months following the intervention's completion. Asthma Control range is 0-6 with lower score better control (0= total control and 6 = extremetly uncontrolled. The minimally important clinical difference is 0.5. A score \> 1.5 is considered

Conditions Studied

Interventions

  • BEHAVIORAL Usual Care
  • BEHAVIORAL Patient Advocate

Study Locations (1)

Pennsylvania

  • University of Pennsylvania Health System - Philadelphia

Trial Details

FieldValue
Enrollment Target 312 participants
Start Date 2013-12-12
Est. Completion 2022-04-30
Phase NA
University of Pennsylvania

1,423 total trials

What the finished NCT01972308 record still lists

NCT01972308 is an interventional study that assigns participants to a tested intervention. The registered 312 participants enrollment target is mid-sized for trials with a published cap, below the 1,563-participant average among 374 other Asthma trials with a reported enrollment target (80% lower).

The record links to 2 conditions, with Asthma appearing as the primary indexed condition, and to 2 interventions - of which Usual Care is the first listed.

NCT01972308 reports a single indexed study location in Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT01972308 about?

NCT01972308 is a clinical study titled "A Patient Advocate to Improve Real-world Asthma Management for Inner City Adults". Few interventions to improve asthma management have targeted low-income minority asthmatic adults and even fewer have focused on the real-world practice where care is provided for these patients. This project tests the effectiveness of a Patient Advocate as a practical and sustainable method of faci...

What is the current status of trial NCT01972308?

This trial is currently completed. It is a NA study. The enrollment target is 312 participants. The study started on 2013-12-12. Estimated completion is 2022-04-30.

What conditions does trial NCT01972308 study?

This clinical trial studies the following conditions: Asthma, Communication.

What interventions are being tested in trial NCT01972308?

The interventions under investigation include: Usual Care (BEHAVIORAL), Patient Advocate (BEHAVIORAL).

Who is sponsoring clinical trial NCT01972308?

This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01972308 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Asthma

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT01972308's enrollment target sits among peer trials

312 121st of 374 higher than 254 of 374 other Asthma trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Asthma trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04984551 · 312 participants · Phase 2

    Impact of Project ECHO on Improving the Quality of Palliative Care in Patients With Advanced Cancer and Their Caregivers in Underserved Areas of Kenya, Nigeria, Ghana, South Africa, India, and Ethiopia

  • NCT04999904 · 312 participants · NA

    A Proprioceptive Training Program Using an Uneven Terrain Treadmill for Patients With Ankle Instability

  • NCT05220332 · 312 participants · NA

    Church-based Intervention to Improve Blood Pressure in African Americans

  • NCT05434234 · 312 participants · Phase 1

    A Study of YL201 in Patients With Advanced Solid Tumors

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT01972308, the US trial registry maintained by the National Library of Medicine. NCT01972308 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.